Evidence map›Paper›PMID 40741021›Full record

ReviewWorld journal of cardiology2025

Integrating liver and heart health: Cardiovascular risk reduction in patients with metabolic-associated steatotic liver disease.

Thang Viet Luong, Hoa Tran, Bich Ngoc Hoang Thi, Hung Minh Vu, The Trung Le, Tien Thi Le, Huyen Trang Tran Thi, Hung Minh Nguyen, Thang Chi Doan, Binh Anh Ho and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Thang Viet LuongDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue 530000, Viet Nam.
Hoa TranDepartment of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh 700000, Viet Nam.
Bich Ngoc Hoang ThiDepartment of Outpatient, Gia An 115 Hospital, Ho Chi Minh City 700000, Viet Nam.
Hung Minh VuDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue 530000, Viet Nam.
The Trung LeDepartment of Nephrology and Endocrinology, Da Nang Hospital, Da Nang 550000, Viet Nam.
Tien Thi LeDepartment of Nephrology and Endocrinology, Da Nang Hospital, Da Nang 550000, Viet Nam.
Huyen Trang Tran ThiDepartment of Endocrinology and Clinical Hematology, 199 Hospital, Da Nang 550000, Viet Nam.
Hung Minh NguyenVietnam National Heart Institute, Bach Mai Hospital, Ha Noi 100000, Viet Nam.
Thang Chi DoanCardiovascular Center, Hue Central Hospital, Hue 530000, Viet Nam.
Binh Anh HoCardiovascular Center, Hue Central Hospital, Hue 530000, Viet Nam.
Tien Anh HoangDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue 530000, Viet Nam.
Hai Nguyen Ngoc DangFaculty of Medicine, Duy Tan University, Da Nang 550000, Viet Nam. ngochai123dc@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic-associated steatotic liver disease (MASLD) is a global health burden intricately linked to cardiovascular disease (CVD) through shared pathways-insulin resistance, dyslipidemia, and chronic inflammation. CVD has become the leading cause of mortality in MASLD, necessitating integrated management strategies. This review synthesizes evidence on bidirectional MASLD-CVD interactions and evaluates therapeutic approaches: Lifestyle modifications, pharmacotherapy (

Indexed as

Bariatric surgeryCardiovascular diseaseEmerging therapiesGLP-1 receptor agonistsInsulin resistanceMetabolic-associated steatotic liver diseaseMultidisciplinary careSGLT2 inhibitorsStatins

Identifiers

PMID40741021
PMCPMC12304865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.